Return On Equity	(Sep 30 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	-73.35 %	-58.38 %	-39.22 %	-32.57 %	97.25 %
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

RLMD all Ratios >> Back to RLMD Management Effectiveness >> See Quarterly RLMD Return On Equity

You need to upgrade your Flash Player

Financial Statements
Relmada Therapeutics Inc's Equity	$ 9 Millions	Annual RLMD's Balance sheet
Relmada Therapeutics Inc's Annual Income	$ -10 Millions	Annual RLMD's Income Statement
Where are RLMD's Income coming from?		Visit RLMD's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.